Top-News

Skye Bioscience Aktie News

Aktie
WKN:  A3ES4X ISIN:  US83086J2006 US-Symbol:  SKYE Branche:  Biotechnologie Land:  USA
1,20 $
-0,01 $
-0,83%
1,0306 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
33,68 Mio. €
Streubesitz
32,47%
KGV
-4,29
Index-Zuordnung
-

Skye Bioscience News

05.12.25 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire
05.12.25 - PR Newswire
Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 ...
04.12.25 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience PR Newswire
04.12.25 - PR Newswire
Shareholders of Skye Bioscience, Inc. Should Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE
Shareholders of Skye Bioscience, Inc. Should Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE PR Newswire
04.12.25 - PR Newswire
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE PR Newswire
04.12.25 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
03.12.25 - PR Newswire
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing PR Newswire
02.12.25 - PR Newswire
SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit PR Newswire
02.12.25 - PR Newswire
Investors in Skye Bioscience, Inc. Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE
Investors in Skye Bioscience, Inc. Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE PR Newswire
01.12.25 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire
01.12.25 - PR Newswire
Skye Bioscience, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - SKYE
Skye Bioscience, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - SKYE PR Newswire
01.12.25 - PR Newswire
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE PR Newswire
01.12.25 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
30.11.25 - PR Newswire
SKYE DEADLINE: Faruqi & Faruqi Reminds Skye Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
SKYE DEADLINE: Faruqi & Faruqi Reminds Skye Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE PR Newswire
25.11.25 - PR Newswire
Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 ...
24.11.25 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire
24.11.25 - PR Newswire
Skye Bioscience, Inc. Class Action: The Gross Law Firm Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
Skye Bioscience, Inc. Class Action: The Gross Law Firm Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, ...
24.11.25 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
21.11.25 - PR Newswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience PR Newswire
21.11.25 - PR Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »